Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab vs Bevacizumab + Laser in Acute RVO
NCT03353324Phase 3Unknown
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2017
- Primary completion
- May 2018
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of bevacizumab in retinal vein occlusion (RVO) and macular edema (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Visual acuity. Status: unknown.
02
Drugs
bevacizumab
03
Conditions
retinal vein occlusion (RVO)macular edema
Beyond the preview
Go deeper on NCT03353324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03353324.